The accountability of the private sector towards citizens in times of crisis: vaccines, medicines and equipment.


Journal

European journal of public health
ISSN: 1464-360X
Titre abrégé: Eur J Public Health
Pays: England
ID NLM: 9204966

Informations de publication

Date de publication:
09 Nov 2021
Historique:
entrez: 9 11 2021
pubmed: 10 11 2021
medline: 12 11 2021
Statut: ppublish

Résumé

In this article, we examine what the role of the private sector in times of crises is and whether the private sector is, and can be held to be, accountable. COVID-19 has amplified the difficulties with public-private partnerships and this article addresses several aspects concerning business enterprises, in particular transnational corporations, human rights and health sector activities, highlighting the key aspects to understand and address accountability issues. The article also explores accountability for the private sector, the processes to ensure accountability, and the relevance of regulation and self-regulation.

Identifiants

pubmed: 34751360
pii: 6423456
doi: 10.1093/eurpub/ckab160
pmc: PMC8576299
doi:

Substances chimiques

Vaccines 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

iv54-iv58

Informations de copyright

© The Author(s) 2021. Published by Oxford University Press on behalf of the European Public Health Association.

Références

Bull World Health Organ. 2018 Nov 1;96(11):782-791
pubmed: 30455533
Tob Control. 2002 Mar;11 Suppl 1:I110-7
pubmed: 11893821
Am J Public Health. 2012 Jan;102(1):72-80
pubmed: 22095335
Milbank Q. 2009 Mar;87(1):259-94
pubmed: 19298423
J Pharm Policy Pract. 2017 Jun 2;10:18
pubmed: 28588896
N Engl J Med. 2017 Dec 14;377(24):2301-2305
pubmed: 29236640
PLoS Med. 2010 Sep 28;7(9):e1000310
pubmed: 20927356

Auteurs

Elena Petelos (E)

Health Technology Assessment Section, European Public Health Association (EUPHA), Utrecht, The Netherlands.
Health Services Research, CAPHRI Care and Public Health Research Institute, Faculty of Health Medicine and Life Sciences, Maastricht University, Maastricht, The Netherlands.
Clinic of Social and Family Medicine, Faculty of Medicine, University of Crete, Iraklion, Greece.

Dimitra Lingri (D)

Department of Law, Faculty of Law, Aristotle University of Thessaloniki, Thessaloniki, Greece.
European Healthcare Fraud and Corruption Network, Brussels, Belgium.

Jinane Ghattas (J)

EUPHAnxt, Utrecht, The Netherlands.
Institute of Health and Society (IRSS), Université catholique de Louvain, Brussels, Belgium.

Silvia M A A Evers (SMAA)

Health Services Research, CAPHRI Care and Public Health Research Institute, Faculty of Health Medicine and Life Sciences, Maastricht University, Maastricht, The Netherlands.
Trimbos Institute, Utrecht, The Netherlands.

Dineke Zeegers Paget (DZ)

EUPHA, Utrecht, The Netherlands.

Chiara de Waure (C)

Health Technology Assessment Section, European Public Health Association (EUPHA), Utrecht, The Netherlands.
Department of Medicine and Surgery, University of Perugia, Perugia, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH